Home/Smart Money/Stonepine Capital Management, LLC
§ 13F · FUND PROFILE

Stonepine Capital Management, LLC.

AUM · $123M (13F)Positions · 58Turnover · n/a · Q2Filed · Aug 17, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$15M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 17, 2026
#TickerNameShares$ value% portΔ Q2
1VSTMVERASTEM INC3.35M$13M3.3%+103%
2EOLSEVOLUS INC1.59M$11M2.8%+85%
3TENXTENAX THERAPEUTICS INC660K$10M2.5%—
4NKTRNEKTAR THERAPEUTICS121K$8M2.2%—
5ADMAADMA BIOLOGICS INC650K$8M2.0%—
6ADMAADMA BIOLOGICS INC740K$6M1.6%+47%
7CAMPCAMP4 THERAPEUTICS CORP1.39M$6M1.6%+100%
8INSMINSMED INC40K$6M1.4%—
9ELOXELOXX PHARMACEUTICALS INC397K$6M1.4%—
10RAREULTRAGENYX PHARMACEUTICAL IN200K$6M1.4%—
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE STONEPINE SIGNAL

AC read

Stonepine Capital Management, LLC is a Other fund managing $123 million in assets. The fund runs a portfolio of 58 positions.

Read the full dossier →